# Minocycline to Treat Central Retinal Vein Occlusion

> **NCT01468844** · PHASE1,PHASE2 · COMPLETED · sponsor: **National Eye Institute (NEI)** · enrollment: 6 (actual)

## Conditions studied

- Retinal Vein Occlusion

## Interventions

- **DRUG:** Minocycline
- **DRUG:** Placebo
- **DRUG:** Bevacizumab

## Key facts

- **NCT ID:** NCT01468844
- **Lead sponsor:** National Eye Institute (NEI)
- **Sponsor class:** NIH
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-12-21
- **Primary completion:** 2015-03-04
- **Final completion:** 2015-05-13
- **Target enrollment:** 6 (ACTUAL)
- **Last updated:** 2021-03-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01468844

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01468844, "Minocycline to Treat Central Retinal Vein Occlusion". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01468844. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*